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An Update on Local 
Anaesthesia in Orthodontics
Abstract: With the increasing use of temporary anchorage devices in orthodontics the use of topical and local anaesthesia is becoming 
more common in everyday practice. The mode of action, types of anaesthetic and the potential local and systemic complications will be 
described.
CPD/Clinical Relevance: A knowledge of local anaesthetics is essential for any orthodontist, particularly with the increasing popularity of 
the use of temporary anchorage devices.
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Until relatively recently, the 
administration and use of local 
anaesthesia (LA) could not be 
counted as part of an orthodontist’s 
routine clinical practice, particularly 
as procedures such as pericision and 
fraenectomy are relatively infrequently 
performed in contemporary 
orthodontics. With the advent of 
temporary anchorage devices, an 
orthodontist is now faced with the 
need to achieve adequate anaesthesia 
to enable their placement. Temporary 
Anchorage Devices (TADs) are the 
most common orthodontic surgically 
placed implants and are placed buccally 
between the roots of teeth in both the 
mandible and maxilla and also palatally 
in the maxilla. Less commonly, mid-
palatal osseointegrated implants can 
be placed and are used in combination 
with appliances such as a palatal arch1 
(Figure 1).
 This article gives an overview 
of pain pathways and the mode of 
action of topical and local anaesthetics, 
along with providing some practical 
tips on their use.
Pain pathways
Pain is ‘an unpleasant sensory 
and emotional experience associated 
with actual or potential tissue damage’.2 
It is detected via free Aδ and C nerve 
fibres in response to physical, chemical 
or thermal stimuli and the substances 
released following tissue damage (eg 
prostaglandins). Pain is transmitted by 
means of action potentials progressing 
along the nerve fibres, and is caused 
by the opening of sodium channels in 
response to depolarization, leading to a 
rapid influx of positively charged sodium 
ions into the cell. This in turn reverses 
the polarity and leads to the outflow of 
potassium ions in an attempt to restore 
the electrochemical gradient (Figure 
2). Local anaesthesia works by entering 
the nerve and inactivating the sodium 
channels, thus preventing depolarization 
and the generation of an action 
potential.3 In this way it blocks sensory 
nerve conduction following nociception.
Neuroanatomy
The innervation of the 
dentition is derived from the branches 
of the trigeminal nerve (the fifth cranial 
nerve), which converge to form the 
Gasserian ganglion before entering the 
brain stem. Sensation to the maxilla is 
supplied by the second division of the 
trigeminal nerve: the maxillary nerve 
(V2). This divides into several branches, 
including the superior alveolar nerve 
(posterior, middle and anterior), the 
greater palatine nerve and the infra-
orbital nerve. Sensation to the mandible 
is supplied by the third division of the 
trigeminal nerve: the mandibular nerve 
(V3). The main branches that are relevant 
in dental anaesthesia are the inferior 
alveolar, long buccal, lingual, mental and 
incisive nerves (Figure 3).
Types of anaesthesia
There are two types of 
anaesthesia used in the fitting of both 
TADs and mid-palatal implants, namely 
topical and infiltrative local anaesthesia.
1. Topical anaesthesia
The placement of TADs 
can often be completed using topical 
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anaesthesia4 and there are definite 
advantages to this approach. One of the 
greatest risks during TAD placement is 
damage to vital structures; tooth roots, 
nerves and blood vessels. The use of 
a topical anaesthetic alone can help 
negate this risk as deeper anaesthesia 
is not achieved and can allow the 
orthodontist to gauge sensation as the 
TAD is placed. If the TAD impinges on the 
roots of the adjacent teeth, the patient 
will complain of some sensitivity and 
the path of insertion of the TAD can be 
altered accordingly. However, mucosal 
anaesthesia alone can sometimes be 
inadequate as the screw penetrates 
bone. Indeed, the efficacy of intra-oral 
topical anaesthetic in dentistry has 
been debated with equivocal results.5,6 
Some studies have shown placement 
of TADs using topical anaesthesia alone 
to have a good overall success rate.4,7−9 
These studies used compound topical 
anaesthetics (CTA) comprising different 
anaesthetic agents (including lidocaine, 
tetracaine, prilocaine and phenylephrine) 
and in various combinations. A 
recent randomized controlled trial 
comparing topical anaesthesia and 
infiltrative anaesthesia during mini-
screw placement found that topical 
anaesthesia was less predictable and 
could be inadequate.9 It should be noted 
that some of the topical anaesthetic 
agents used in these studies are not 
available in the UK. The agents currently 
available in the UK are Septodont Xylonor 
5% Lidocaine Gel, Septodont Xylocaine 
10% Lidocaine Spray and Optident Ltd 
Ultracare 17.9% Benzocaine Gel. More 
evidence is required to ascertain if these 
products would be appropriate for use 
as the sole anaesthetic agent for TAD 
placement.
Another advantage 
associated with the use of topical 
anaesthetic alone is avoiding the need 
for infiltrative anaesthesia, which is a 
cause of patient anxiety and reduced 
patient co-operation.10 It has been 
suggested that the use of topical 
anaesthesia can reduce nociception, 
not only through its pharmacological 
mechanisms, but also by virtue of a 
significant psychological effect.11 Many 
orthodontic patients have previously not 
experienced an interventional dental 
procedure, including the administration 
of local anaesthetic, and so a topical 
anaesthetic can therefore also be used 
prior to the use of infiltrative anaesthesia 
in order to reduce nociception.
A topical anaesthetic is 
simply a concentrated form of local 
anaesthetic, which is applied locally. 
There are a number of topical intra-oral 
anaesthetics discussed in the literature, 
including benzocaine, amethocaine and 
lidocaine. The more commonly used 
intra-oral anaesthetics in dentistry 
are benzocaine and lidocaine.12 There 
is evidence to suggest that Eutectic 
Mixture of Local Anaesthetics (EMLA) is 
effective for palatal topical anaesthesia, 
although not licensed and therefore not 
approved for intra-oral use.12
Topical anaesthetics are 
available in many flavours to improve 
tolerance, particularly in children. 
They are also available in a number 
of forms, including gels, sprays, 
creams, controlled delivery devices 
and dressings, and can be used both 
extra- and intra-orally. The form of 
topical anaesthetic preparation can 
alter the effectiveness of the drug, with 
some evidence of increased efficacy 
with the intra-oral use of film strips,13 
microneedles14 and liposome delivery, 
incorporating the local anaesthetic 
Figure 1. A mid-palatal implant for anchorage 
reinforcement.
Figure 2. The effect of a local anaesthetic (LA) on the action potential within an afferent pain neuron.
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into artificially created phospholipid 
vesicles.15,16
To reach the required site, 
intra-oral topical anaesthetics must 
cross the mucosal barrier. As a result, 
the concentration of drug required 
is higher than that used in infiltrative 
anaesthesia, in order to ensure 
adequate local anaesthetic reaches the 
target site.12
Factors affecting the efficacy 
of intra-oral topical anaesthetics 
include the type and formulation 
of the anaesthetic, anatomical 
site, pH, concentration and time 
applied to mucosa.12,17,18 Unlike 
infiltrative anaesthesia, adding a 
vasoconstrictor has not been shown 
to influence the effectiveness of 
topical anaesthetics.19 The length of 
time the topical anaesthetic is applied 
affects the penetrative depth of the 
anaesthesia.20 It is therefore important 
that the manufacturer’s instructions are 
adhered to in order to ensure adequate 
anaesthesia. The site of application also 
governs the degree of efficacy of the 
anaesthetic, with effectiveness reduced 
on more highly keratinized tissues 
(eg palatal mucosa),21 and increased 
effectiveness in the mandibular buccal 
sulcus compared with the maxillary 
buccal sulcus.22
The side-effect profile of 
intra-oral topical anaesthetics has 
been shown to be minimal, with the 
exception of cocaine, which has been 
associated with localized necrosis and 
systemic effects,23−25 and is therefore no 
longer licensed for dental applications. 
Adverse reactions include localized 
tissue responses or systemic reactions. 
The latter will be described later 
under systemic complications of 
local anaesthetics. Absorption via the 
mucous membranes amongst children 
is increased due to increased vascularity 
and cardiac output26 and therefore 
dosage should be monitored closely 
to avoid the risk of systemic toxicity, 
particularly if used in combination with 
infiltrative anaesthesia.
How to use topical anaesthetic 
preparations
Prior to using a topical 
anaesthetic preparation, the oral 
mucosa should be dried and the topical 
applied using a cotton wool pledget/
bud (Figure 4). It has been shown that 
the application time of an intra-oral 
topical anaesthetic is important in 
determining its efficacy. This time can 
vary from as little as 10 seconds up 
to several minutes, depending on the 
product, but commonly an application 
time of two minutes is sufficient.12, 27
2. Infiltrative local anaesthetic
Local anaesthetics belong 
to one of two classes dependent on 
the side chain present on the active 
molecule. They are either amides or 
esters. Esters are now only used in 
topical anaesthetics, whereas amides 
are used in cartridge form for infiltrative 
anaesthesia. Both esters and amides 
have both hydrophilic and lipophilic 
properties, which allows them to 
penetrate through both interstitial 
fluids and the fatty nerve sheaths.28
There are many types of 
infiltrative local anaesthetic available 
and those used in dentistry include 
lidocaine, articaine, mepivacaine and 
prilocaine (Table 1). Lidocaine 2% with 
1:80,000 adrenaline is a widely used 
local anaesthetic in dentistry and has 
Figure 4. Prior to using a topical anaesthetic 
preparation, the oral mucosa should be dried 
and the topical anaesthetic applied using a 
cotton wool pledget/bud.
Figure 3. The three branches of the trigeminal nerve (green − mandibular branch; red − maxillary 
branch; blue − ophthalmic branch).
Orthodontics 89July 2018
a good safety profile. Detailed below 
is the maximum dosage for lidocaine 
in adults and children. For further 
information on maximum dosages 
please refer to the current summary of 
product characteristics (SPCs) from the 
manufacturer.
Adults (18 years +)
The amount of anaesthetic 
administered is dependent on the 
procedure to be undertaken. For the 
placement of TADs or implants, only 
a small volume is usually required. 
However, it should be borne in mind that 
the maximum recommended dose of 
lidocaine is 4.4 mg/kg of body weight, 
with a maximum dose of 300 mg. A 2% 
solution of lidocaine equates to 20 mg/
ml, or 44 mg in a 2.2 ml cartridge, hence 
one cartridge per 10 kg, to a maximum 
of approximately 7 cartridges (308 mg).
Adrenaline at a concentration 
of 1:80 000 corresponds to 12.5 
microgram/ml or 27.5 micrograms in 
a 2.2 ml cartridge. The recommended 
maximum dose of adrenaline is 0.2 
mg,29 and therefore a similar rule of 7 
cartridges may be applied (0.19 mg). 
Care should be taken in patients with 
known cardiac history.
Adolescents (12−18 years) and children 
(4−11 years)
Special care has to be 
exercised when treating children. The 
minimum quantity of anaesthetic should 
be administered in order to perform the 
procedure adequately. The maximum 
dose is determined by the weight of 
the child. Obviously, the anaesthestic 
technique should be selected carefully, 
painful anaesthesia techniques should 
be avoided and the behaviour of 
the child during treatment has to be 
monitored carefully. The maximum dose 
for children is the same as for adults, 
namely 4.4 mg/kg.30
There are several 
components within the typical dental 
local anaesthetic cartridge and 
these include the local anaesthetic, a 
vasoconstrictor and a reducing agent. 
There may also be a carrier solution and 
nitrogen bubble.
 The vasoconstrictor helps to 
reduce local blood flow and therefore 
increases the safety of local anaesthetic 
in the following ways:
 1. Minimizes haemorrhage;
 2. Reduces the peak plasma 
concentration of the LA;
 3. Reduces possible systemic 
effects;
 4. Increases the duration of 
action.31
A local anaesthetic 
solution containing adrenaline should 
therefore be used where possible. 
Where haemostasis is not a priority, the 
concentration of adrenaline may be 
reduced, 1:100 000 and 1:200 000 being 
available, with equivalent anaesthetic 
efficacy.32−34 The reducing agent (eg 
sodium bisulphite) helps to prevent the 
vasoconstrictor from becoming oxidized 
by reacting with any oxygen. An isotonic 
solution is added to reduce any osmotic 
effects and a small nitrogen bubble 
helps to prevent the presence of oxygen 
which could lead to degradation of the 
vasoconstrictor.28
As already described, there 
are several different local anaesthetic 
agents available for use in dentistry. 
They vary in features such as duration of 
anaesthesia, onset of action and efficacy. 
Two commonly used local anaesthetic 
agents in dentistry are lidocaine and 
articaine. There are suggestions that 
articaine achieves a higher success rate of 
anaesthesia by infiltration administration 
than lidocaine.35 However, either agent 
can be used to good effect. The maximum 
permissible doses of these more commonly 
used anaesthetics are illustrated in Table 1.
How to use local infiltrative anaesthesia
In order to administer infiltrative 
local anaesthesia, the mucosa should be 
pulled taut, the bevel of the needle placed 
close to the reflection of the mucosa (for 
a buccal infiltration) or into the palate 
(for a palatal infiltration) and the needle 
advanced until it reaches the target area. At 
this point, the syringe should be aspirated. 
If any blood is noted in the syringe, no 
infiltration should take place, the needle 
should be moved and re-aspirated. This 
helps to prevent administration directly 
into a blood vessel and thereby helps 
to limit any systemic effects of the local 
anaesthetic. In order to reduce pain, the 
local anaesthetic should be deposited 
slowly.
 
Local anaesthesia in the 
presence of inflamed tissues
Local anaesthetic is less 
effective in inflamed tissue. There are 
several mechanisms postulated to be the 
cause for this. The pH of the tissues is more 
acidic during inflammation, holding the LA 
in the ionized form and reducing the ability 
of the LA to cross the lipid membrane of 
the cell. The tissues are also subject to 
hyperaemia and therefore LA is carried 
away faster. There are increased levels of 
inflammatory factors and it is thought that 
these could also play a role in altered LA 
effects.2,36 It is therefore important when 
placing TADs to avoid placement around 
inflamed tissues and to ensure adequate 
anaesthesia.
Complications of local 
anaesthesia
Local anaesthetics are generally 
very safe and effective drugs, however, 
there are several complications that can 
occur following their administration. 
Fortunately, while these are rarely 
encountered, clinicians must be aware of 
them. Broadly, these can be categorized as 
local or systemic in nature.
Local effects
Needle breakage
This is a rare complication that 
Local 
Anaesthetic
Vasoconstrictor Reducing 
Agent
Maximum 
Dose
(mg/kg)
Maximum
Total Dose
(mg)
Lidocaine 2% Adrenaline Bisulphite 4.4 300
Mepivacaine 2% Adrenaline Bisulphite 4.4 300
Mepivacaine 3% None None 4.4 300
Prilocaine 3% Felypressin None 6 400
Articaine 4% Adrenaline Bisulphite 7 500
Table 1. The formulations of typically used dental local anaesthetic cartridges including the maximum 
permissible doses.30
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can usually be resolved by removing 
the remaining needle portion with 
college tweezers, where visible. If not 
visible, removal requires a referral to an 
oral and maxillofacial surgery (OMFS) 
unit.
Pain
The administration of local 
anaesthetic using infiltration may be 
a painful experience for the patient. 
Ways to overcome this include the 
use of topical anaesthesia, injecting 
the fluid slowly and ensuring that it 
is at room temperature at the time of 
administration. Anaesthetics should 
not be stored in the fridge, and instead 
should be stored at room temperature 
not exceeding 25°C.
Inadequate anaesthesia
This can be due to a 
number of reasons; variations in patient 
anatomy, incorrect placement, injection 
directly into a blood vessel, insufficient 
anaesthetic used, or injection into 
inflamed tissue.
Nerve damage
If a nerve is directly 
traumatized during infiltration, there is 
a potential for complications, including 
anaesthesia, dysaesthesia, paraesthesia 
and hyperalgesia. Fortunately, this 
complication is more common when 
using inferior alveolar (IAN) and 
lingual nerve blocks and these are 
not routinely used in orthodontics, eg 
during TAD placement.
Anaesthetic spread
Once again, this is a more 
common complication of an IAN block 
rather than a local infiltration during 
orthodontic procedures. Anaesthetizing 
unwanted nerves (eg the facial nerve) 
can occur with incorrect anaesthetic 
placement and can result in unwanted 
effects (eg facial nerve palsy − unilateral 
facial paresis on incorrect IAN block 
placement).2,28,37
Systemic effects
Vasovagal syncope
There is reduced blood flow 
to the brain secondary to vasodilation 
and decreased heart rate. The patient 
can become dizzy, pale and can 
temporarily lose consciousness. This is 
most frequently related to stress and 
anxiety.38 Treatment is to lay the patient 
flat, lift the legs and provide oxygen.39
Toxicity
Toxicity can result if too much 
local anaesthetic is administered. There 
is an increased risk of this in children 
and those with liver or kidney disease. 
Fortunately, during TAD placement the 
amount of anaesthetic placed should 
be small and not lead to a risk of 
toxicity. However, it is important to be 
aware of the risks. An overdose of local 
anaesthetic can have effects on both the 
central nervous system (CNS) and the 
cardiovascular system. CNS symptoms 
include dizziness, tinnitus, increased 
blood pressure and CNS depression. 
Cardiovascular effects include decreased 
contraction strength and heart rate. If an 
overdose is suspected, referral to hospital 
is recommended.2,40
Vasoconstriction
Injection of a vasoconstrictor 
directly into a blood vessel can lead to 
increased heart rate and blood pressure. 
This can be avoided by ensuring to 
aspirate prior to injection. Blanching of 
areas of skin supplied downstream of 
vasoconstriction may be observed.
Allergy
Allergy to local anaesthetic 
is rare and is usually attributed to the 
bisulphate reducing agent, which 
is added to stabilize the adrenaline 
contained within most local anaesthetics. 
If there is a history of suspected allergy 
to local anaesthetic, a referral for allergy 
testing is indicated. Anaphylaxis is a 
rare complication and should be treated 
as per the medical emergencies and 
resuscitation guidelines.39
Fortunately, complications 
associated with the use of local 
anaesthetic administration are rare. The 
taking of a full medical history prior to 
administration is mandatory and can help 
avoid problems. Patients may experience 
more adverse side-effects with local 
anaesthetics if they have cardiovascular, 
pulmonary, liver or kidney disease, or 
are pregnant. It is also important to 
ensure that the maximum dose of local 
anaesthetic is considered on an individual 
basis.37,40 If any serious complications are 
encountered, a referral to the accident 
and emergency department (A&E) or to 
the local oral and maxillofacial surgery 
(OMFS) team is warranted.
Summary
A knowledge and 
understanding of local anaesthetic 
agents and their delivery is important to 
ensure safe and effective anaesthesia, 
particularly with the increased use of 
TADs. Complications are infrequent, 
however, an awareness of their 
management is an important skill 
for any orthodontic practitioner 
considering their use.
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1.  D
2.  B
3.  C
4.  C
5.  C
6.  A
7. D
